The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IACH MATH 2020 | Update on auto-SCT for myeloma
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, gives an update on the status of autologous stem cell transplant (auto-SCT) for multiple myeloma. Specifically, Prof. Mohty discusses the advances in induction therapy, the optimal conditioning regimen, as well as consolidation and maintenance therapy after auto-SCT. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
